Prère M F, Lefèvre J C, Lareng M B
Chemotherapy. 1981;27 Suppl 1:15-8. doi: 10.1159/000238023.
The study was carried out with 50 strains of gonococci. Susceptibility to the antibiotics was determined by standard sensitivity test, by systematic test for beta-lactamase and by measurement of the MICs. The cephalosporins tested were: moxalactam, cefotaxime, ceftriaxone, cefotiam, cefoxitin, cefazolin and cephalothin. Their activities were also compared with other beta-lactams, namely penicillin and ampicillin. The efficacy in vitro of the cephalosporins: in the lead, ceftriaxone, remarkably active, with cefotaxime following very close, and then moxalactam with cefotiam a little behind, and finally all the other beta-lactams tested. The median MICs of the new cephalosporins (moxalactam, cefotaxime, ceftriaxone and cefotiam) were at least 10 times greater than those of the other beta-lactams tested. The MIC values observed with a resistant strain (penicillin, ampicillin; MIC 256 microgram/ml) never exceed the maximum values found with the 50 susceptible strains.
该研究使用了50株淋病奈瑟菌。通过标准敏感性试验、β-内酰胺酶系统检测以及最小抑菌浓度(MIC)测定来确定这些菌株对各种抗生素的敏感性。所检测的头孢菌素包括:拉氧头孢、头孢噻肟、头孢曲松、头孢替安、头孢西丁、头孢唑林和头孢噻吩。它们的活性还与其他β-内酰胺类药物(即青霉素和氨苄西林)进行了比较。头孢菌素的体外疗效:领先的是头孢曲松,活性显著,头孢噻肟紧随其后,然后是拉氧头孢,头孢替安稍落后,最后是所有其他检测的β-内酰胺类药物。新型头孢菌素(拉氧头孢、头孢噻肟、头孢曲松和头孢替安)的中位MIC至少比其他检测的β-内酰胺类药物高10倍。用一株耐药菌株(青霉素、氨苄西林;MIC为256微克/毫升)观察到的MIC值从未超过50株敏感菌株所发现的最大值。